Literature DB >> 7092177

Local cerebral glucose metabolism in newborn dogs: effects of hypoxia and halothane anesthesia.

T E Duffy, M Cavazzuti, N F Cruz, L Sokoloff.   

Abstract

Local cerebral glucose utilization (LCGU) was measured in 36 neuroanatomical structures of normal awake, halothane-anesthetized, and hypoxic newborn puppies by the autoradiographic 2-[14C]deoxyglucose method. In normal animals, LCGU was highest in the vestibular nucleus and in other gray matter nuclei of the brainstem and declined in a caudal-to-rostral progression through the neuraxis (i.e., LCGU of cerebellum greater than thalamus approximately equal to caudate-putamen greater than cerebral cortex). Lowest rates of glucose metabolism were detected in white matter structures. Halothane anesthesia (1.5% inspired) caused few changes in local glucose metabolism, the most notable being decreased LCGU among structures of the auditory system (cochlear nucleus, lateral lemniscus, inferior colliculus) and increased LCGU in the interpeduncular nucleus. Acute systemic hypoxia (arterial oxygen tension of approximately 12 mm Hg) produced markedly heterogeneous effects on local glucose metabolism: LCGU was increased in some gray matter structures, decreased in the thalamus, and substantially increased in the subcortical white matter and corpus callosum. In puppies whose brains were frozen in situ after 55 minutes of hypoxia, the concentration of lactate was increased ten- to elevenfold in cortical gray and subcortical white matter, but the concentrations of glucose, adenosine triphosphate, and phosphocreatine declined to a greater extent in the white matter. The results suggest that during hypoxia the high rate of glycolysis in white matter exceeded substrate supply so that glucose availability became the limiting factor for local energy production. Such a mechanism may contribute to the white matter injury that often develops following hypoxic-ischemic insults in the perinatal period.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092177     DOI: 10.1002/ana.410110303

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  6 in total

1.  Evaluation of Disease Lesions in the Developing Canine MPS IIIA Brain.

Authors:  Leanne K Winner; Neil R Marshall; Robert D Jolly; Paul J Trim; Stephen K Duplock; Marten F Snel; Kim M Hemsley
Journal:  JIMD Rep       Date:  2018-06-20

2.  Brain glucose utilization in mice with a targeted mutation in the thyroid hormone alpha or beta receptor gene.

Authors:  Y Itoh; T Esaki; M Kaneshige; H Suzuki; M Cook; L Sokoloff; S Y Cheng; J Nunez
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 3.  Dogs as a Natural Animal Model of Epilepsy.

Authors:  Wolfgang Löscher
Journal:  Front Vet Sci       Date:  2022-06-22

4.  Cerebral metabolic effects of organophosphorus anticholinesterase compounds.

Authors:  A L Miller; M A Medina
Journal:  Metab Brain Dis       Date:  1986-06       Impact factor: 3.584

5.  Adaptive decreases in amino acids (taurine in particular), creatine, and electrolytes prevent cerebral edema in chronically hyponatremic mice: rapid correction (experimental model of central pontine myelinolysis) causes dehydration and shrinkage of brain.

Authors:  J H Thurston; R E Hauhart; J S Nelson
Journal:  Metab Brain Dis       Date:  1987-12       Impact factor: 3.584

6.  Pyruvate kinase activity in cerebral hemispheres and cerebellum-brainstem of normal and hypoxic-ischemic newborn rats.

Authors:  Hacer Yapicioglu; Mehmet Satar; Levent Kayrin; Ercan Tutak; Nejat Narli
Journal:  Cerebellum       Date:  2004       Impact factor: 3.648

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.